bmiMD Tirzepatide Reviews 2026: Compounded GLP-1/GIP From $139 a Month
By Charly P. · Published August 6, 2026 · 9 min read
bmiMD sells compounded tirzepatide — the dual GLP-1/GIP molecule — on a term ladder that runs from $179/mo month-to-month down to $139/mo on twelve months. That is competitive but not remarkable. What is remarkable is four words on the product page: same price at every dose. Dose escalation is the single biggest hidden cost in compounded GLP-1 pricing, and a provider that removes it has removed the thing most likely to blow up your budget in month four. Here is how the ladder works, what bmiMD publishes about its pharmacy testing, and where the marketing gets ahead of the substance.
bmiMD Tirzepatide at a Glance
| Medication | Compounded GLP-1/GIP (tirzepatide) |
|---|---|
| Format | At-home weekly injection |
| Price Range | $139–$179/mo depending on term length |
| Dose Pricing | Same price at every dose |
| Provider Visit | Included |
| Shipping | Free on every subscription order; expedited delivery |
| Clinician Access | 24/7, 100% online |
| Eligibility Refund | 100% refundable if not eligible for the program |
| Pharmacy Testing | Potency, sterility (USP 797), endotoxicity (USP 85), pH |
| FDA Status | Compounded — not FDA-approved |
| Rating Displayed | 4.9 average, 1,000+ reviews |
| Payment Options | Buy now, pay later available |
| Also Offered | Mood + energy, strength + cardio, anti-aging, peptides (coming soon) |
What Is bmiMD?
bmiMD is a telehealth platform whose stated mission is helping patients reach weight loss and metabolic goals through access to GLP-1 treatments, clinical oversight, metabolic testing as necessary, and ongoing support from board-certified physicians. Its weight loss line sits alongside mood and energy, strength and cardio, and anti-aging programs, with peptides listed as coming soon.
bmiMD is already a familiar name on this site — we have reviewed its NAD+ therapy program separately. The tirzepatide offer is a different product with different economics, and it is the stronger of the two on price structure. For where it sits against the wider market, our best weight loss providers list is the fastest comparison.
bmiMD Pricing: The Term Ladder
bmiMD prices by commitment length. The longer the term, the lower the monthly rate — a standard structure, but the spread here is wide enough to matter.
| Term | Monthly rate | Cost of the full term |
|---|---|---|
| 1 month | $179/mo | $179 |
| 3 months (most flexible) | $159/mo | $477 |
| 6 months (most popular) | $149/mo | $894 |
| 12 months (best value) | $139/mo | $1,668 |
Twelve months at $139 costs $1,668. Twelve months bought one month at a time costs $2,148. The commitment is worth $480 a year — real money, and also a real bet, because you are paying ahead for a medication you may not tolerate. The three-month tier at $477 is the sensible middle: enough runway to get through dose titration and find out how your body responds, without a year of exposure.
“Same Price at Every Dose” Is the Headline Here
Compounded tirzepatide is normally titrated upward over months — you start low to manage side effects and increase toward a maintenance dose. At many providers, the price climbs with the dose. The $149 you were quoted at 2.5mg is not the number you pay at 10mg, and buyers routinely discover this in month three or four, after the comparison shopping is over.
bmiMD says the price does not move. That converts its ladder from an entry price into an actual budget, and it is the reason this program compares better than its headline number suggests. When you put it against FeelGood Meds at $149 “starting at,” or Shed, which publishes a $239/mo twelve-month tirzepatide rate but no dose-tier table behind it, the flat-dose commitment is the thing that actually differentiates bmiMD — not the $139.
What bmiMD Publishes About Pharmacy Testing
Compounded medication lives or dies on the pharmacy behind it, and most platforms say nothing more specific than “state-licensed.” bmiMD publishes the actual test panel, which is unusual and worth crediting.
- ✓Potency — confirmed every 3 to 6 months to stay within ±10% of target strength
- ✓Sterility — screened for bacteria, fungi and other contaminants to USP 797 standards
- ✓Endotoxicity — checked to USP 85 limits for bacterial toxins
- ✓pH — adjusted for a smooth, irritation-free injection
- ✓Prepared in a state-licensed pharmacy, independently verified in FDA- and DEA-registered labs
bmiMD also states that compounded medication uses ingredients solely from FDA-licensed sources and that it works exclusively with licensed sterile compounding pharmacies across the United States. None of this makes a compounded product FDA-approved — bmiMD says so itself, plainly, in its own disclosures — but it is meaningfully more disclosure than the category norm.
Compounded Tirzepatide vs. Zepbound
| Factor | bmiMD compounded tirzepatide | Zepbound (branded) |
|---|---|---|
| FDA approval | Not FDA-approved; not evaluated by the FDA | FDA-approved for chronic weight management |
| Price at bmiMD | $139–$179/mo, flat across doses | Not sold by bmiMD |
| Dispensing | Licensed sterile compounding pharmacy | Retail pharmacy |
| Provider visit | Included in the program price | Billed separately |
bmiMD is straightforward about this distinction in its own compliance language, noting that Zepbound is FDA-approved for chronic weight management and that Ozempic is FDA-approved for type 2 diabetes but may be prescribed off-label for weight management. On the underlying molecule, direct comparative research has associated tirzepatide with greater average weight reduction than semaglutide, which is why the dual GLP-1/GIP mechanism commands a premium almost everywhere it is sold.
How the bmiMD Program Works
- 1.Complete the assessment
You answer a health questionnaire online. bmiMD states this assessment does not create a doctor-patient relationship — it is the input a clinician uses to decide whether treatment is appropriate.
- 2.Clinician review and prescribing decision
Clinical services are provided by doctor networks of US-licensed clinicians who determine eligibility from your medical history and responses. Providers retain full discretion to prescribe or decline. If you are not eligible, bmiMD advertises a 100% refund.
- 3.Delivery and ongoing support
Medication ships with expedited delivery and free shipping on subscription orders, with easy refills, 24/7 clinician access, and metabolic testing as necessary.
The refund-if-ineligible policy deserves a note. Being declined after paying a consultation fee is a common and frustrating outcome across this category, and several competitors describe their consultation fees as non-refundable once completed. bmiMD taking the opposite position removes the main financial risk of simply finding out whether you qualify.
Who bmiMD Tirzepatide Is Best For
This suits the buyer who has already decided on tirzepatide specifically, is comfortable with compounded medication, and wants a price that will still be true at a maintenance dose. If you are willing to commit to six or twelve months, the $149 and $139 rates are at the competitive end of the market for a dual GLP-1/GIP product with the visit included.
It suits you less if you want the FDA-approved product — bmiMD does not sell Zepbound, and says so. It also suits you less if you are needle-averse or want to start on semaglutide; RxActivate publishes a semaglutide rate alongside tirzepatide, which makes it easier to compare the two molecules at one provider. And if you want the medication to sit inside a broader lifestyle program, note that the National Institute of Diabetes and Digestive and Kidney Diseases notes these medications work best combined with one, and that regain is likely after stopping.
bmiMD Tirzepatide Pros & Cons
Pros
- ✓Same price at every dose — removes the biggest hidden cost in compounded GLP-1 pricing
- ✓Term ladder from $179/mo down to $139/mo, published openly
- ✓Provider visit included rather than billed separately
- ✓100% refundable if you are not eligible for the program
- ✓Publishes its actual pharmacy test panel: potency ±10%, USP 797 sterility, USP 85 endotoxicity, pH
- ✓Free shipping on every subscription order plus expedited delivery
- ✓24/7 clinician access and easy refills, entirely online
- ✓Clear, unusually candid compliance language about compounded medication and FDA status
- ✓Buy now, pay later available
Cons
- ✗Compounded tirzepatide is not FDA-approved and has not been evaluated for safety, efficacy or quality
- ✗The best rates require a six or twelve-month commitment paid ahead of knowing your tolerance
- ✗Countdown-timer urgency ("Summer Closeout") is applied to pricing that is likely to recur
- ✗No branded Zepbound option for patients who require the FDA-approved product
- ✗Tirzepatide only in this program — no semaglutide tier to step down to on price
- ✗The 4.9 rating and 1,000+ review count are displayed without naming the review platform
- ✗Clinical services run through third-party doctor networks rather than in-house clinicians
Bottom Line
Our Editorial Take
Most GLP-1 platforms compete on the entry price and quietly recover margin at the maintenance dose. bmiMD has given that up, and flat-dose pricing plus an included provider visit makes its ladder one of the few in this category you can actually plan against. Publishing the pharmacy test panel — potency tolerance, USP 797, USP 85 — points the same way: this is a company willing to be specific where specificity can be checked.
The friction is the sales layer around it. A countdown clock on a seasonal promotion, a 4.9 rating with no platform named, and best pricing gated behind six or twelve months paid up front are all pulling against the credibility the rest of the page earns. The compounded status is a genuine trade-off too, though bmiMD states it more plainly than most.
One of the stronger compounded tirzepatide offers we have reviewed, on structure rather than headline price. Start on three months at $477 rather than the twelve-month rate, confirm the flat-dose pricing in writing, and step up the term once you know how you tolerate it.
bmiMD Alternatives
Comparing bmiMD against other GLP-1 programs? These are the top-rated weight loss providers we recommend:
Tirzepatide is also available as an FDA-approved brand-name product, and our Pallas Health review looks at a program where a clinician can route you to either that or a compounded preparation from the same intake.
Recommended Providers
Our editorial team’s top picks for this category.
bmiMD Tirzepatide: Frequently Asked Questions
Recommended Providers
Our editorial team’s top picks for this category.
Weighing tirzepatide against other options? Start with our best weight loss treatments guide.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.